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The authors of guidelines provide 100 recommendations
describing many intensively discussed issues. Among them
is hepatotoxicity of PTU and limitation of PTU treatment
mainly to the first trimester of pregnancy. Methimazole
becomes first line ATD for patients with new onset of
Graves’ disease. Graves’ orbitopathy (GO) is classified
according to its clinical activity and severity. Deterioration
of GO after radioactive iodine (RAI) treatment and benefi-
cial effects of steroids to prevent RAI induced exacerba-
tion of GO are described. All patients with subclinical
thyrotoxicosis who are older than 65 years and those who
are below age 65 and have risk factors or hyperthyroid
symptoms should be treated. It is proposed to measure
TSH receptor autoantibodies in pregnant women with a
previous history of autoimmune thyroid disease. The
information about thyroid ultrasonography with the col-
our-flow Doppler for the rapid differentiation between the
two main types of amiodarone-induced thyrotoxicosis, and
its help for accurate treatment of these conditions is
provided.
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